http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 13 Jul 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Sana+Biotechnology+Announces+Follow-On+Publication+in+The+New+England+Journal+of+Medicine+%28NEJM%29+Highlighting+Groundbreaking+Long-Term+Data+and+Durability+of+Hypoimmune-Modified+Islet+Cell+Transplanta/26759975.html <p align="center"><em>Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in 2025</em></p> <p align="center"><em>Seminal Study Successfully Achieved Primary and Secondary Endpoints, Demonstrating that Hypoimmune (HIP)-Modified Islets are Safe, Evade Detection by the Immune System, Survive, and Function Long-Term and Continue to Produce Insulin in the Patient for Over One Year Following Administration Without Immunosuppression</em></p> <p align="center"><em>Sana Expects to File Investigational New Drug (IND) Application </em><em>and Initiate Phase 1/2 </em><em>Trial as Early as This Year </em><em>for SC451, a HIP-Modified, Stem Cell-Derived http://www.streetinsider.com/Press+Releases/Sana+Biotechnology+Announces+Follow-On+Publication+in+The+New+England+Journal+of+Medicine+%28NEJM%29+Highlighting+Groundbreaking+Long-Term+Data+and+Durability+of+Hypoimmune-Modified+Islet+Cell+Transplanta/26759975.html Mon, 13 Jul 2026 08:00:00 -0400 SANA http://www.streetinsider.com/Globe+Newswire/Sana+Biotechnology+Announces+Follow-On+Publication+in+The+New+England+Journal+of+Medicine+%28NEJM%29+Highlighting+Groundbreaking+Long-Term+Data+and+Durability+of+Hypoimmune-Modified+Islet+Cell+Transplanta/26759975.html <p align="center"><em>Peer-Reviewed Letter to the Editor Describes Updated Long-Term Findings Consistent with Initial Trial Data Featured in NEJM Article Published in 2025</em></p> <p align="center"><em>Seminal Study Successfully Achieved Primary and Secondary Endpoints, Demonstrating that Hypoimmune (HIP)-Modified Islets are Safe, Evade Detection by the Immune System, Survive, and Function Long-Term and Continue to Produce Insulin in the Patient for Over One Year Following Administration Without Immunosuppression</em></p> <p align="center"><em>Sana Expects to File Investigational New Drug (IND) Application </em><em>and Initiate Phase 1/2 </em><em>Trial as Early as This Year </em><em>for SC451, a HIP-Modified, Stem Cell-Derived http://www.streetinsider.com/Globe+Newswire/Sana+Biotechnology+Announces+Follow-On+Publication+in+The+New+England+Journal+of+Medicine+%28NEJM%29+Highlighting+Groundbreaking+Long-Term+Data+and+Durability+of+Hypoimmune-Modified+Islet+Cell+Transplanta/26759975.html Mon, 13 Jul 2026 08:00:00 -0400 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jul+06++Filed+by%3A+Bishop+Hans+Edgar/26742189.html si-local-file:///var/storage/secattach/20260707/26742189.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jul+06++Filed+by%3A+Bishop+Hans+Edgar/26742189.html Tue, 07 Jul 2026 16:31:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jul+06++Filed+by%3A+Bishop+Hans+Edgar/26742189.html si-local-file:///var/storage/secattach/20260707/26742189.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jul+06++Filed+by%3A+Bishop+Hans+Edgar/26742189.html Tue, 07 Jul 2026 16:31:00 -0400 O.49824919 SANA http://www.streetinsider.com/Press+Releases/Sana+Biotechnology+Announces+Symposium+Presentation+at+the+European+Association+for+the+Study+of+Diabetes+%28EASD%29+Annual+Meeting+2026/26717655.html <p>SEATTLE, July 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced a symposium presentation highlighting clinical data from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana’s hypoimmune platform (HIP) technology, into a patient with type 1 diabetes without any immunosuppression. The symposium will be held at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 taking place from September 28 - October 2, 2026 in Milan, Italy.</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td http://www.streetinsider.com/Press+Releases/Sana+Biotechnology+Announces+Symposium+Presentation+at+the+European+Association+for+the+Study+of+Diabetes+%28EASD%29+Annual+Meeting+2026/26717655.html Wed, 01 Jul 2026 09:00:00 -0400 SANA http://www.streetinsider.com/Globe+Newswire/Sana+Biotechnology+Announces+Symposium+Presentation+at+the+European+Association+for+the+Study+of+Diabetes+%28EASD%29+Annual+Meeting+2026/26717655.html <p>SEATTLE, July 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced a symposium presentation highlighting clinical data from an investigator-sponsored, first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana’s hypoimmune platform (HIP) technology, into a patient with type 1 diabetes without any immunosuppression. The symposium will be held at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 taking place from September 28 - October 2, 2026 in Milan, Italy.</p> <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td http://www.streetinsider.com/Globe+Newswire/Sana+Biotechnology+Announces+Symposium+Presentation+at+the+European+Association+for+the+Study+of+Diabetes+%28EASD%29+Annual+Meeting+2026/26717655.html Wed, 01 Jul 2026 09:00:00 -0400 SANA http://www.streetinsider.com/Analyst+Comments/Sana+Biotechnology+%28SANA%29+Reiterated+at+Market+Outperform+by+Citizens+/26715817.html <p>Citizens analyst Reni Benjamin reiterated a Market Outperform rating and $8.00 price target on Sana Biotechnology (NASDAQ: SANA).</p><p>The analyst commented, " File IND for SG293 (CD8/CD19 In Vivo CAR T program). SG293 is the first candidate from Sana's fusogenbased in vivo CAR-T platform. It uses a CD8-targeted virus-like particle to deliver a CD19 CAR specifically into CD8+ T cells, where it integrates into the cell’s DNA for durable expression. The design is also intended to allow transduction of resting T cells, reduce anti-CAR immunogenicity, and limit off-target delivery. Preclinical NHP data presented at ASGCT 2026 showed cell-specific delivery, dose-dependent CAR-T http://www.streetinsider.com/Analyst+Comments/Sana+Biotechnology+%28SANA%29+Reiterated+at+Market+Outperform+by+Citizens+/26715817.html Wed, 01 Jul 2026 04:54:26 -0400 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Yang+Patrick+Y/26611832.html si-local-file:///var/storage/secattach/20260605/26611832.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Yang+Patrick+Y/26611832.html Fri, 05 Jun 2026 16:44:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Yang+Patrick+Y/26611832.html si-local-file:///var/storage/secattach/20260605/26611832.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Yang+Patrick+Y/26611832.html Fri, 05 Jun 2026 16:44:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Rosiello+Robert+L./26611815.html si-local-file:///var/storage/secattach/20260605/26611815.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Rosiello+Robert+L./26611815.html Fri, 05 Jun 2026 16:41:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Rosiello+Robert+L./26611815.html si-local-file:///var/storage/secattach/20260605/26611815.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Rosiello+Robert+L./26611815.html Fri, 05 Jun 2026 16:41:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Seitz+Michelle/26611779.html si-local-file:///var/storage/secattach/20260605/26611779.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Seitz+Michelle/26611779.html Fri, 05 Jun 2026 16:40:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Seitz+Michelle/26611779.html si-local-file:///var/storage/secattach/20260605/26611779.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Seitz+Michelle/26611779.html Fri, 05 Jun 2026 16:40:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+REICIN+ALISE/26611737.html si-local-file:///var/storage/secattach/20260605/26611737.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+REICIN+ALISE/26611737.html Fri, 05 Jun 2026 16:38:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+REICIN+ALISE/26611737.html si-local-file:///var/storage/secattach/20260605/26611737.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+REICIN+ALISE/26611737.html Fri, 05 Jun 2026 16:38:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Mulligan+Richard/26611712.html si-local-file:///var/storage/secattach/20260605/26611712.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Mulligan+Richard/26611712.html Fri, 05 Jun 2026 16:37:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Mulligan+Richard/26611712.html si-local-file:///var/storage/secattach/20260605/26611712.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Mulligan+Richard/26611712.html Fri, 05 Jun 2026 16:37:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bishop+Hans+Edgar/26611662.html si-local-file:///var/storage/secattach/20260605/26611662.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bishop+Hans+Edgar/26611662.html Fri, 05 Jun 2026 16:35:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bishop+Hans+Edgar/26611662.html si-local-file:///var/storage/secattach/20260605/26611662.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bishop+Hans+Edgar/26611662.html Fri, 05 Jun 2026 16:35:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bilenker+Joshua+H./26611629.html si-local-file:///var/storage/secattach/20260605/26611629.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bilenker+Joshua+H./26611629.html Fri, 05 Jun 2026 16:33:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bilenker+Joshua+H./26611629.html si-local-file:///var/storage/secattach/20260605/26611629.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+Bilenker+Joshua+H./26611629.html Fri, 05 Jun 2026 16:33:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+NELSEN+ROBERT/26611435.html si-local-file:///var/storage/secattach/20260605/26611435.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+NELSEN+ROBERT/26611435.html Fri, 05 Jun 2026 16:25:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+NELSEN+ROBERT/26611435.html si-local-file:///var/storage/secattach/20260605/26611435.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04++Filed+by%3A+NELSEN+ROBERT/26611435.html Fri, 05 Jun 2026 16:25:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04/26611009.html si-local-file:///var/storage/secattach/20260605/26611009.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04/26611009.html Fri, 05 Jun 2026 16:05:00 -0400 O.49824919 SANA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04/26611009.html si-local-file:///var/storage/secattach/20260605/26611009.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Sana+Biotechnology%2C+Inc.++For%3A+Jun+04/26611009.html Fri, 05 Jun 2026 16:05:00 -0400 O.49824919 SANA